Exchange: NASDAQ·Updated 06:57 PM EDT

ETNB 89bio Inc

$14.95
$0.00
(0.00%)
Today
Closed $14.84
$0.11
(0.74%)
After Hours
Reported EarningsAug 7
Mkt Cap$2.2B
Vol55.65M

About ETNB

89bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. Its product pipeline includes pegozafermin, FGF21, NASH, and SHTG. The company was founded on January 18, 2018 and is headquartered in San Francisco, CA.
42

Bearish Sentiment

How do you feel about ETNB?

Advertisement|Remove ads.